Vanguard Group Inc Arcturus Therapeutics Holdings Inc. Transaction History

Vanguard Group Inc

$5.46 Trillion
Q3 2024

A detailed history of Vanguard Group Inc transactions in Arcturus Therapeutics Holdings Inc. stock. As of the latest transaction made, Vanguard Group Inc holds 1,576,926 shares of ARCT stock, worth $25.6 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

1,576,926

Previous 1,384,744 13.88%

Holding current value

$25.6 Million

Previous $33.7 Million 8.55%

% of portfolio

0.0%

Previous 0.0%

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 13, 2024	BUY	$18.08 - $25.38 $3.47 Million - $4.88 Million	192,182 Added 13.88%	1,576,926 $36.6 Million
Q2 2024 Aug 13, 2024	SELL	$24.35 - $44.39 $76,702 - $139,828	-3,150 Reduced 0.23%	1,384,744 $33.7 Million
Q1 2024 May 10, 2024	SELL	$31.23 - $42.99 $2.2 Million - $3.03 Million	-70,486 Reduced 4.83%	1,387,894 $46.9 Million
Q4 2023 Feb 14, 2024	BUY	$17.71 - $32.97 $912,720 - $1.7 Million	51,537 Added 3.66%	1,458,380 $46 Million
Q3 2023 Nov 14, 2023	SELL	$25.44 - $37.35 $5.64 Million - $8.28 Million	-221,573 Reduced 13.61%	1,406,843 $35.9 Million
Q2 2023 Aug 14, 2023	BUY	$23.94 - $32.36 $3.9 Million - $5.28 Million	163,070 Added 11.13%	1,628,416 $46.7 Million
Q1 2023 May 15, 2023	BUY	$14.72 - $23.97 $219,637 - $357,656	14,921 Added 1.03%	1,465,346 $35.1 Million
Q4 2022 Feb 10, 2023	BUY	$14.14 - $23.06 $1.61 Million - $2.62 Million	113,607 Added 8.5%	1,450,425 $24.6 Million
Q3 2022 Nov 14, 2022	BUY	$13.05 - $22.13 $1.87 Million - $3.17 Million	143,162 Added 11.99%	1,336,818 $19.8 Million
Q2 2022 Aug 12, 2022	BUY	$12.26 - $31.17 $492,153 - $1.25 Million	40,143 Added 3.48%	1,193,656 $18.8 Million
Q1 2022 May 13, 2022	BUY	$17.64 - $39.57 $110,973 - $248,934	6,291 Added 0.55%	1,153,513 $31.1 Million
Q4 2021 Feb 14, 2022	BUY	$34.2 - $47.56 $1.14 Million - $1.58 Million	33,271 Added 2.99%	1,147,222 $42.5 Million
Q3 2021 Nov 12, 2021	SELL	$27.88 - $58.25 $1.84 Million - $3.84 Million	-65,890 Reduced 5.58%	1,113,951 $53.2 Million
Q2 2021 Aug 13, 2021	BUY	$25.79 - $42.11 $30.4 Million - $49.7 Million	1,179,841 New	1,179,841 $39.9 Million

Others Institutions Holding ARCT

# of Institutions

179

Shares Held

25.6M

Call Options Held

195K

Put Options Held

133K

View Full List

About Arcturus Therapeutics Holdings Inc.

Ticker ARCT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 26,576,400
Market Cap $432M
Description
Arcturus Therapeutics Holdings Inc., an RNA medicines company, focuses on the development of vaccines for infectious, and liver and respiratory rare diseases in the United States. The company's development programs comprise LUNAR-OTC development program for ornithine transcarbamylase (OTC) deficiency; and LUNAR-CF program for cystic fibrosis lun...

More about ARCT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Vanguard Group Inc, based on Form 13F filings with the SEC.

News

Stay updated on Vanguard Group Inc with notifications on news.

Account

Vanguard Group Inc Arcturus Therapeutics Holdings Inc. Transaction History